Background {#Sec1}
==========

The term low birthweight (LBW) is defined by the World Health Organization (WHO) as the weight at birth of a neonate less than 2500 g (g), a cut-off that is often consistent with 10th percentile for gestation \[[@CR1], [@CR2]\]. This cut-off was based on epidemiological observations that neonates of birthweight less than 2500 g were more likely to die than heavier newborns \[[@CR3]\], with mortality rates rising rapidly as birthweight decreases \[[@CR4]--[@CR6]\]. WHO advises that the 2500 g cut-off value should be used for international health statistics comparisons \[[@CR1]\].

Low birthweight is an important public health indicator of maternal malnutrition and health, and poor antenatal care \[[@CR1], [@CR3]\]. Globally, more than 20 million newborns (an estimated 15.5% of all births) are born low birthweight each year. More than 95% of these LBW neonates are born in low- and middle-income countries (LMICs) \[[@CR1]\]. There is significant variation of LBW rates among geographical regions. The highest LBW rates are seen in Asia (18.3%), about three times higher than the lowest rate, in Europe (6.4%). There is considerable variation between sub-regions in Asia, ranging from 5.9% in Eastern Asia to 27% in South-central Asia \[[@CR1], [@CR7]\].

LBW has been associated with increased risks of neonatal mortality and several neonatal morbidities, including birth asphyxia, acute respiratory infections and diarrhea disease, as well as longer-term adverse health outcomes such as neurological disorders, impaired language development, poor academic performance, cardiovascular disease and diabetes \[[@CR3], [@CR8], [@CR9]\]. Decreasing the global burden of LBW could substantially reduce costs to families and o healthcare systems in LMICs \[[@CR10]\].

However, some evidence has emerged that the cut-off value of 2500 g to define LBW may not be appropriate for all settings. For example, some countries such as Sri Lanka have a high prevalence of neonates with birthweight less than 2500 g do not have correspondingly high neonatal mortality rates \[[@CR11]\]. To this effect, WHO suggested that individual countries should adopt a population-specific cut-off value for LBW to guide clinical care \[[@CR1]\]. However, in practice a birthweight below 2500 g is still in routine use in most LMICs.

Defining an appropriate LBW cut-off is challenging. If too low, some neonates may not get necessary care. Alternatively, if the value is too high, some neonates may get additional care that is not necessary. In many LMICs, inappropriate use of limited health resources can disadvantage neonates requiring more intensive care. Therefore, further investigation of the most appropriate cut-off for LBW remains an important issue.

Previous studies have defined population-specific cut-offs for LBW in high-income countries (HICs) \[[@CR12], [@CR13]\] and LMICs \[[@CR14], [@CR15]\]. This is typically done using statistical methods, where the lowest 10th percentile of the birthweight distribution is used as the cut-off for LBW. These has often resulted in LBW cut-offs higher than 2500 g -- for example, 2750 g in the US in 1992 \[[@CR12]\] to 3000 g in Denmark in 2007 \[[@CR13]\]. Recent studies in LMICs have also identified alternative LBW cut-offs, such as 2600 g in a study in sub-urban Cameroon \[[@CR14]\] and 2700 g in a rural community \[[@CR15]\] in Cameroon.

Previous studies have used an outcome-based approach for identification of cut-off weights for fetal growth \[[@CR16]\] and macrosomia \[[@CR17]\]. By using the Health Statistics database for the years 1995--2002 of the United State National Center, Joseph et al. generated fetal growth standards for singleton and twin neonates based on severe morbidity and mortality outcomes \[[@CR16]\]. In a secondary analysis of the database of the World Health Organization (WHO) Global Survey on Maternal and Perinatal Health (2004--2008) conducted in 23 LMICs in Africa, Asia, and Latin America, Ye et al. defined macrosomia based on the adjusted assoiated risk of birthweight for maternal and perinatal mortality and morbidity in term pregnancies \[[@CR17]\]. However, we have identified no previous analyses that have defined a LBW cut-off value using an outcome-based approach. This study therefore aimed to identify an outcome-based definition of LBW for LMICs using the WHO Global Survey database.

Methods {#Sec2}
=======

Study design and population {#Sec3}
---------------------------

We conducted a secondary analysis using data from the WHO Global Survey (WHOGS) on Maternal and Perinatal Health conducted in Africa, Asia and Latin America. The WHOGS was a prospective, facility-based, cross-sectional survey on maternal and perinatal health interventions and outcomes. The primary aim of the survey was to assess the association between mode of birth and maternal and perinatal health outcomes \[[@CR18], [@CR19]\]. Details of the survey have been reported elsewhere \[[@CR18]--[@CR20]\]. A total of 373 facilities in 24 countries in three regions participated in this survey. Data collection was performed in 2004--05 for Africa and Latin America, and in 2007--08 for Asia. Trained data collectors reviewed medical records of individual women from the time of attending participating facilities for delivery until discharge, death or day 7 postpartum. Data were abstracted from medical records into structured case record forms. The period of data collection was two months in facilities with at least 6000 deliveries per year and three months in facilities with less than 6000 deliveries per year. Institutional data were collected for each participating facility, including information on available resources for obstetric care. The data was obtained through an interview with the hospital director or head of obstetrics, and data entered into the pre-specified institutional form.

The WHOGS protocol was approved by the WHO ethics review committee and the relevant local review committees for all participating centres \[[@CR19]\]. Individual informed consent was not obtained; survey data were extracted from medical records without individual identification or patient contact \[[@CR19]\]. We received permission to use this data from the Department of Reproductive Health and Research, WHO on January 14th, 2014.

Our analysis was restricted to singleton, live newborns in participating facilities in low- and middle-income countries (facilities and newborns in Japan were excluded). We aimed to evaluate associations between birthweight cut- offs and early neonatal mortality (ENM). ENM was defined as death occurring in hospital prior to discharge or Day 7 (whichever came first). We adjusted for potential confounders, including maternal complications (such as chronic hypertension, sickle cell anaemia) gestational age at birth, mode of birth and fetal presentation at birth. Newborns with missing information on birthweight, ENM outcome and potential confounders were excluded. We also excluded facilities that had less than 50 newborns \[[@CR21]\]. The selection process for the analysis population is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow chart of inclusion and exclusion of study neonates

We used data on the availability of basic and essential maternal healthcare services of individual participating facilities as potential confounding factors at facility level. Facilities were classified into different levels, using the existing WHOGS facility capacity index (FCI) score \[[@CR18]\]. FCI scores ranged between 0 and 16. Facilities with a total score of 9 or less were defined as low capacity, those with scores of between 10 and 12 as medium capacity, and those with scores of 13 or more as high capacity \[[@CR18]\].

Statistical analysis {#Sec4}
--------------------

We assessed the association of birthweight groups with ENM using two-level logistic regression models. We assigned facilities to represent units at level two and individuals within facilities at level one. We used the birthweight range of 2500--3499 g as the reference group based on the current global clinical practice for normal neonatal birthweight range. In addition, the rates of ENM at 100 g intervals within 2500 -- 3499 g were quite similar (around 0.5% in our database) \[see Additional file [1](#MOESM1){ref-type="media"}\]. We classified birthweights of 1500--2499 g into 100 g intervals. Birthweights less than 1500 g were classified into one group. We adjusted for potential confounders at both levels in the models (see above). We estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of ENM by absolute birthweight subgroups. We analysed all associations in the whole database and by region (Africa, Asia and Latin America).

It is well-known that the risk of adverse neonatal outcomes increases as birthweight decreases; very low birthweight infants (1500 g or less) are at greatest risk \[[@CR22]--[@CR25]\]. We applied this concept in our analysis to identify an appropriate low birthweight cut-off based on the ENM. We used an a priori odds ratio threshold of 2.0 (for the lower confidence interval) as a criterion for clinical significance, as per previous studies \[[@CR17], [@CR26], [@CR27]\]. Thus, in this analysis the clinical significance was defined as when the lower limit of the 95% confidence interval for the adjusted OR was at least 2.0 \[[@CR28]\]. We, therefore, defined LBW from the lowest birthweight of the subgroup that its lower subgroups had lower limit of the 95% confidence interval for adjusted OR was at least 2.0 \[[@CR28]\].

The descriptive analyses were also done using R software. We used package lme4 of R software to analyse the two-level logistic regression model \[[@CR29]\].

Results {#Sec5}
=======

A total of 205,648 singleton live newborns at 344 facilities in 23 LMICs were included in this analysis (Fig. [1](#Fig1){ref-type="fig"}). There were differences in the birthweight distribution for the three regions. Mean birthweights were 2935 g (SD 389 g) in Africa, 2838 g (SD 406 g) in Asia and 2958 g (SD 428 g) in Latin America. The rates of birthweight \< 2500 g were 9.9, 14.2 and 10.8%, in Africa, Asia and Latin America respectively. The rates of birthweight \< 1500 g were 0.8, 0.8 and 1.4%, in Africa, Asia and Latin America respectively. Wide variation of birthweight was observed between Asian countries (Table [1](#Tab1){ref-type="table"}).Table 1Country-specific birthweight and early neonatal mortality distribution of singleton liveborn birthsCountriesNumber of facilitiesNumber of newbornsBirthweight (g)Early Neonatal Mortality (%)Mean(SD)\<  1500 (%)\<  2500 (%)Total344205,6482902(413)1.012.00.8 Africa11852,6032935(389)0.89.91.1  Algeria1875163025(390)1.07.41.3  Angola1539202903(405)1.211.80.5  Congo2167672874(392)0.614.41.0  Kenya2013,5862921(395)1.09.71.8  Niger1165262906(381)0.511.60.4  Nigeria2157042932(380)0.98.20.8  Uganda1285842964(363)0.67.71.1 Asia11285,2222838(406)0.814.20.7  Cambodia544572897(383)0.89.31.1  China2193573045(332)0.45.50.3  India2022,0082653(405)1.222.11.1  Nepal868522786(386)0.513.70.9  Philippines1711,7322819(419)1.316.21.1  Sri Lanka1413,1912846(381)0.615.50.2  Thailand1280682939(380)0.710.80.4  Viet Nam1595572997(335)0.35.70.1 Latin America11467,8232958(428)1.410.80.7  Argentina1466612975(453)1.911.00.5  Brazil1910,9552956(437)1.511.60.8  Cuba1783003013(379)0.78.00.2  Ecuador1496662898(432)1.512.40.7  Mexico2115,7162932(429)1.511.60.6  Nicaragua642712946(384)0.79.51.0  Paraguay620012990(442)1.610.41.1  Peru1710,2532997(438)1.79.81.0

We present the associations between birthweight intervals and potential confounding factors in Table [2](#Tab2){ref-type="table"}. Mean gestational age was positively associated with birthweight. Higher rates of all potential confounding factors were seen among infants with lower birthweights. In the study population, the caesarean section rate was 24.3 and 16.9% of women had a maternal complication.Table 2Distribution of individual potential confounding factors by birthweightBirthweight (g)nGestational ageCesarean sectionBreech presentation at birthMaternal complications^a^Mean(SD)(%)(%)(%)Overall205,64838.5(2.0)49,964 (24.3)9099 (4.4)34,642 (16.9)\<  1500207230.6(4.1)38.918.625.31500--159960233.1(3.2)32.411.120.31600--169952133.7(3.1)39.312.122.51700--179981134.4(3.0)35.812.120.31800--189997334.6(2.9)35.910.422.11900--1999103235.2(2.9)36.79.523.32000--2099280736.7(2.6)26.77.515.72100--2199216536.9(2.5)29.77.319.22200--2299381737.2(2.3)26.26.415.62300--2399417837.6(2.0)25.55.218.22400--2499562837.9(2.0)25.95.518.72500--3499181,04238.8(1.6)23.73.916.6All variables differed significantly by birthweight categories (*p*-value \< 0.001)^a^Maternal complications included chronic hypertension, cardiac disease, renal disease, chronic respiratory condition, diabetes mellitus, malaria, sickle cell anaemia, severe anaemia, pyelonephritis or urinary infection, HIV/AIDS, Thalassemia and other medical conditions

ENM rates were 1.1, 0.7 and 0.7% in Africa, Asia and Latin America respectively. When compared to the reference (normal birthweight) group (2500--3499 g), adjusted ORs of ENM show statistical significance when birthweight was lower than 2500 g in the total population and each region. However, adjusted ORs of ENM in birthweights of 2300--2399 g in Africa (aOR 1.7 (95% CI; 0.9, 3.3)) and Asia (aOR 1.3 (95% CI; 0.6, 2.7)) did not reach statistical significance.

The adjusted ORs of ENM were similar (about 2.0) for birthweight intervals 2400-2499 g and 2200-2299 g, compared to the reference group. The adjusted ORs gradually increased from 3.8 (95% CI; 2.7, 5.5) for birthweights of 2100--2199 g to 17.9 (95% CI; 13.3, 24.1) in birthweights of 1500--1599 g (Fig. [2](#Fig2){ref-type="fig"}). The adjusted OR increased up to 32.0 (95% CI; 25.6, 40.0) in birthweight \< 1500 g (Table [3](#Tab3){ref-type="table"}). Based on the pre-defined clinical significance criterion for aOR (lower limit of 95% CI of 2.0), the LBW cut-off was 2200 g for the total population.Fig. 2Adjusted odds ratios with 95% CI of early neonatal mortality by birthweight in the total population. Solid red line shows the adjusted OR 2.0 for clinical significanceTable 3Rate and adjusted odds ratios of early neonatal mortality by birthweightBirthweight (g)nEarly Neonatal Mortality^a^Rate (%)Adjusted OR (95% CI)\<  1500207229.032.0 (25.6, 40.0)1500--159960213.817.9 (13.3, 24.1)1600--16995219.612.5 (8.8, 17.7)1700--17998116.29.5 (6.8, 13.2)1800--18999736.810.5 (7.8, 14.1)1900--199910323.65.9 (4.1, 8.5)2000--209928073.16.6 (5.2, 8.5)2100--219921651.63.8 (2.7, 5.5)2200--229938171.02.6 (1.9, 3.7)2300--239941780.61.7 (1.1, 2.6)2400--249956280.72.3 (1.7, 3.1)2500--3499181,0420.31.0Adjusted for gestational age, mode of delivery, fetal presentation at delivery, maternal complications and complexity index^a^*ROC* = 0.9118

When compared to the reference group (2500--3499 g), the adjusted ORs of ENM in birthweight of \< 2500 g were high across all three regions, similar to the total population. However, the adjusted ORs of ENM in birthweight of \< 1500 g in Asia reached 54.3 (95% CI; 37.4, 78.9) while those in Africa and Latin America was 30.4 (95% CI; 21.1, 43.7) and 18.1 (95% CI; 11.5, 28.5), respectively (Table [4](#Tab4){ref-type="table"}).Table 4Rate and adjusted odds ratios of early neonatal mortality by birthweight and regionsBirthweight (g)Early neonatal mortalityAfrica^a^ (*n* = 52,603)Asia^b^ (*n* = 85,222)Latin America^c^ (*n* = 67,823)nRate (%)Adjusted OR (95% CI)nRate (%)Adjusted OR (95% CI)nRate (%)Adjusted OR (95% CI)\<  150043536.830.4 (21.1, 43.7)67728.554.3 (37.4, 78.9)96025.818.1 (11.5, 28.5)1500--159911422.820.6 (11.9, 35.7)32711.923.1 (14.9, 36.0)16111.213.9 (7.5, 25.5)1600--169911614.711.0 (6.0, 20.4)2097.715.6 (8.5, 28.5)1968.712.4 (6.8, 22.8)1700--17991437.76.4 (3.2, 12.7)3875.913.4 (8.2, 22.0)2815.78.8 (4.8, 16.1)1800--189917512.611.5 (6.8, 19.5)4587.016.3 (10.6, 25.2)3403.55.2 (2.7, 10.3)1900--19992286.66.5 (3.7, 11.6)4312.87.4 (3.9, 13.9)3732.74.4 (2.2, 9.0)2000--20996364.15.5 (3.6, 8.6)15712.77.4 (5.1, 10.7)6003.28.3 (4.8, 14.3)2100--21994812.73.6 (2.0, 6.5)9990.82.7 (1.3, 5.6)6852.06.1 (3.4, 10.9)2200--22996822.23.0 (1.8, 5.2)22250.72.3 (1.4, 4.0)9100.93.0 (1.4, 6.3)2300--23999011.11.7 (0.9, 3.3)20430.31.3 (0.6, 2.7)12340.62.6 (1.3, 5.5)2400--249912931.32.2 (1.3, 3.6)27720.52.2 (1.3, 3.7)15630.63.0 (1.5, 5.8)2500--349947,3990.51.073,1230.21.060,5200.11.0Adjusted for gestational age, mode of delivery, fetal presentation at delivery, maternal complications and complexity index^a^*ROC* = 0.8804^b^*ROC* = 0.9101^c^*ROC* = 0.9245

With regards to the pre-defined clinical significance criterion, in Africa the adjusted OR was 3.6 (95% CI; 2.0, 6.5) in birthweights of 2100--2199 g. In Asia, the adjusted OR was 7.4 (95% CI; 5.1, 10.7) in birthweights of 2000--2099 g. In Latin America, the adjusted OR was 6.1 (95% CI; 3.4, 10.9) in birthweights of 2100-2199 g. Therefore, the LBW cut-offs were 2200 g, 2100 g and 2200 g for Africa, Asia and Latin America respectively (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Adjusted odds ratios with 95% CI of early neonatal mortality by birthweight in the three regions. Solid red line shows the adjusted OR 2.0 for clinical significance

Discussion {#Sec6}
==========

Our findings show that a low birthweight cut-off based on ENM outcome is 2200 g for a large, multi-country population of live singleton newborns. The low birthweight cut-off at regional level were similar, 2200 g, 2100 g and 2200 g for Africa, Asia and Latin America respectively. These LBW cut-offs are lower than the traditional criterion of 2500 g. The risks of ENM were quite similar among newborns in with birthweight ranges of 2200--2299 g, 2300--2399 g and 2400--2499 g with adjusted ORs around two, but their lower limit of the 95% confidence intervals did not reach our pre-specified criterion for clinical significance.

Although the a priori adjusted OR of 2.0 for ENM was arbitrarily set as clinically important, the value has been used in previous studies. Ye et al. \[[@CR17]\] used the OR of 2.0 to define macrosomia that is clinically significant risk for maternal and perinatal mortality and morbidity in LMICs, also using the WHOGS database. Boulet et al. \[[@CR27]\] also used this value for defining clinically important fetal growth restriction. Barrette et al. \[[@CR26]\] used the inverse value of 2.0 relative risk (0.5) to clinically justify difference between the planned caesarean delivery and vaginal delivery in the randomized trial of the Twin Birth Study Collaborative Group. However, previous studies \[[@CR17], [@CR26], [@CR27]\] did not report whether the clinically significant OR of 2.0 was identified with respect to the lower 95% confidence interval. This concept has been suggested by Mccluskey \[[@CR28]\] in which clinical significance of any data has to be above or below the range of confidence interval that shows statistical significance. We consider these findings to be reliable in identify the clinically important outcome-based definition of low birthweight using ENM as a primary outcome.

The findings of this analysis are outcome-based criteria for which the definition of low birthweight was identified from the association model between birthweight and ENM adjusted for important confounding factors, maternal complications, gestational age at birth, mode of birth, fetal presentation and facility complexity index. The analyses were performed in the large, multi-country dataset of the WHO Global Survey \[[@CR18]\]. Our findings based on the outcome-based approach done in the large database may be more appropriate than those based on statistical criteria \[[@CR14], [@CR30]--[@CR34]\]. For example, Brimblecombe \[[@CR30]\] suggested the classification of low birthweight based on birthweight distributional components. This study proposed two Gaussian distributions to describe birthweight - the primary distribution was composed of the majority of birthweights, whereas the secondary distribution was the minority of high-risk birthweights centered at the lower tail of the primary distribution. In 1980 Rooth proposed a definition of low birthweight based on a cut-off of weights less than two standard deviations below the local population mean, that better predicted risk for neonatal mortality \[[@CR31]\]. Wilcox and Russell proposed an approach to explain association between birthweight and perinatal mortality. They suggested three parameters should define birthweight characteristics of a population: 1) mean and 2) standard deviation of the Gaussian distribution that included between 95 and 98% of term birthweight population, and 3) the proportion of all births in the residual distribution that mostly consisted of small preterm birth \[[@CR32]--[@CR34]\]. Recently, Njim et al. \[[@CR14]\] conducted a two-phased observational study to set a clinical cut-off point for LBW and to assess its incidence, predictors and complications in a sub-urban hospital in Cameroon. The authors found 2600 g was the cut-off at the 10th centile of birth weight for low birthweight. The cut-off point provided significant higher incidence of low birthweight (19%) than that of the traditional cut-off of 2500 g (13.5%). They also showed that newborns with birthweights between 2500 g and 2600 g had significant higher rates of complications than those with birthweights \> 2600 g in the study population. Agbor et al. \[[@CR15]\] also performed a study with a similar objective and method to Njim et al.'s paper in a rural sub-division in Cameroon. They assessed the statistical LBW cut-off at the 10th percentile of the observed birthweights distribution. They also made the comparison of neonatal adverse outcomes between LBW (birthweight \<10th percentile) and heavier neonates (birthweight ≥10th percentile) in the study population for assessing the clinical significance. The authors reported the clinical cut-off point for LBW at 2700 g in the rural community in Cameroon. They found 6.1% of neonates had birthweights between 2500 g and 2700 g, with higher stillbirth rate (about 3 %, 5/163) than those of heavier neonates (\< 1 %, 12/1553).

In our findings the odds of ENM clearly increased for every 100 g reduction of birth weight after 2200 g. Malin et al. reported a similar finding in a systematic review - a birthweight less than 1500 g had the highest odds of neonatal mortality (OR 48.6, 95% CI 28.62, 82.53). Increasing the birthweight cut-off point to 2000 g, 2500 g or 2900 g gradually reduced the risk, but the summary estimates remained highly significant at each cut-off point \[[@CR14]\]. This review did not report the risk of neonatal mortality by a narrower birthweight range (100 g each) as we did.

This study was a secondary analysis of the WHO Global Survey database conducted in 23 countries across Africa, Asia and Latin America. Trained personnel systematically collected the data. In the analyses, we controlled for important confounding factors of ENM such as maternal complications, gestational age at delivery, and mode of birth. However, the WHOGS database was primarily aimed at evaluating different modes of delivery and pregnancy outcomes, rather than to explore newborn birthweights specifically. The WHOGS was a facility-based survey, performed in large, secondary and tertiary facilities where caesarean section was available. Our findings might lead to over-representation of neonatal adverse outcomes and consequently might not reflect the situation in smaller facilities. There might be errors in birthweight data due to variations between facilities in the quality of birthweight measurement. For example, medical personnel might preferentially report birthweight values ending in a rounded number (0 or 5) which may affect the study findings. Our primary outcome focused only on early neonatal death occurring prior to discharge or day 7; information was not available on late neonatal or infant deaths. The cross-sectional study design only permits us to evaluate associations rather than causation.

Conclusions {#Sec7}
===========

Our analysis suggests that the outcome-based definition of LBW of less than 2200 g may be used instead of the conventional less than 2500 g for assessing BW risk for early neonatal mortality. A regional specific definition of low birthweight (\< 2200 g in Africa, \< 2100 g in Asia and \< 2200 g in Latin America) are quite similar and may be more appropriate for each region.

Additional file
===============

 {#Sec8}

Additional file 1:The percentage of early neonatal mortality by 100 g interval of birthweights. The rates of ENM among 100 g intervals of these birthweights are quite similar of around 0.5% in our analysed database. (PDF 185 kb)
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